Cite Filings / IRD / 0000919574-19-000760
Feed Companies Filings Check
Sign in
SC 13G

Amended Statement of Ownership

Opus Genetics, Inc. · Filed 2019-02-05 · Acc 0000919574-19-000760

Documents 1

  • SC 13G Amended Statement of Ownership , d8176590_13g.htm

Around this filing

  • 2020-08-10 SC 13G Amended Statement of Ownership
  • 2019-02-05 SC 13G Amended Statement of Ownership
  • 2019-02-04 PRE 14A Proxy Statement (Preliminary)
  • 2019-02-04 4 Director bought 10,000 shares at $0.64 ($6,380)
  • 2019-01-31 4 Director bought 15,000 shares at $0.61 ($9,141)
  • 2019-01-31 4 Chief Business Officer bought 20,000 shares at $0.65 ($12,960)
  • 2018-10-29 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Caligan Partners LP 6.2%
  2. 2026-11-16 SCHEDULE 13G · Boxer Capital Management, LLC 5.4%
  3. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 9.99%
  4. 2026-11-16 SCHEDULE 13G · Cormorant Asset Management, LP 6.61%
  5. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 7.36%
Loading d8176590_13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…